Investor Alert: Action Needed for Sage Therapeutics Stakeholders
Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors who may have suffered considerable financial losses due to their investment in Sage Therapeutics, Inc. (NASDAQ: SAGE). Investors with losses exceeding $75,000 are particularly encouraged to engage with the firm to explore their legal options.
Your Investment Rights Matter
If you’ve incurred significant losses in Sage between specific timeframes and want to understand your rights, it's crucial to act promptly. Faruqi & Faruqi's Securities Litigation Partner, Josh Wilson, is available for direct communication at 877-247-4292, where he can discuss the next steps regarding potential claims.
Overview of Alleged Misconduct
The firm is currently investigating potential claims against Sage Therapeutics, as certain allegations have been raised. Throughout a set class period, the firm claims that misleading statements may have been made about the company's business practices and the efficacy of its products. The alleged issues include the effectiveness and approval prospects of zuranolone, SAGE-718, and SAGE-324, raising concerns about Sage's transparency.
Time is of the Essence
There exists a critical deadline for investors—the ability to join the lead plaintiff role in a class action lawsuit is time-sensitive. The key date to remember is October 28, 2024. The lead plaintiff will be instrumental in guiding the class action, and any member affected can present their case through their chosen counsel.
Encouraging Transparency and Participation
Faruqi & Faruqi, LLP encourages any individuals with knowledge about Sage's operations, including whistleblowers and former employees, to come forward. Your information may be valuable in building a stronger case and holding the company accountable.
Faruqi & Faruqi: A Trusted Partner
Established in 1995, Faruqi & Faruqi, LLP has a strong track record, recovering hundreds of millions of dollars on behalf of investors. This legal firm operates out of various states across the country, offering dedicated support to those seeking justice for financial losses.
Taking Action Together
To learn more about the ongoing investigation and find out how you can participate, visit the firm’s dedicated page for Sage Therapeutics. Each investor's decision to join as a lead plaintiff or remain an absent participant will not impact their potential recovery, leaving room for individual choices.
Frequently Asked Questions
What is the deadline to file claims against Sage Therapeutics?
The deadline to seek the role of lead plaintiff in the class action is October 28, 2024.
Who should I contact if I’ve suffered losses with Sage?
Investors are encouraged to contact Josh Wilson at Faruqi & Faruqi directly to discuss their legal options.
What allegations are being made against Sage Therapeutics?
The allegations involve misleading statements about the effectiveness of its treatments and business operations.
Can I still file a claim if I did not suffer significant losses?
While those with losses above $75,000 are being specifically targeted, it's best to consult with legal counsel for individual circumstances.
Is Faruqi & Faruqi a reputable firm?
Yes, Faruqi & Faruqi has a strong history of recovering funds for investors, demonstrating commitment and expertise in securities litigation.
